InspireMD Inc
XBER:II2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
C
|
Canadian Tire Corporation Ltd
F:YAAA
|
CA |
|
GE Vernova Inc
F:Y5C
|
US |
|
S
|
Scor SE
OTC:SZCRF
|
FR |
|
Anglo American PLC
F:NGLD
|
UK |
|
M
|
Markel Corp
F:MKV
|
US |
|
C
|
CVB Financial Corp
F:BCV
|
US |
|
P
|
Prudential Financial Inc
F:PLL
|
US |
|
R
|
Royal Caribbean Cruises Ltd
XBER:RC8
|
US |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
C
|
China Resources Beer Holdings Co Ltd
SWB:CHK
|
HK |
|
L
|
London Stock Exchange Group PLC
DUS:LS4C
|
UK |
|
S
|
Semirara Mining and Power Corporation
XPHS:SCC
|
PH |
|
M
|
Mondi PLC
JSE:MNP
|
UK |
|
Italian Exhibition Group SpA
MIL:IEG
|
IT |
|
Diageo PLC
LSE:DGE
|
UK |
|
C
|
China Pacific Insurance Group Co Ltd
F:75CB
|
CN |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
G
|
General Electric Co
PAR:GNE
|
US |
|
H
|
Hongkong Land Holdings Ltd
XMUN:HLH
|
BM |
|
P
|
Pilgrims Pride Corp
F:6PP
|
US |
Wall St Price Targets
II2 Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for II2 is 30.444 EUR with a low forecast of 24.665 EUR and a high forecast of 34.189 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is II2's stock price target?
Price Target
30.444
EUR
According to Wall Street analysts, the average 1-year price target for II2 is 30.444 EUR with a low forecast of 24.665 EUR and a high forecast of 34.189 EUR.
What is the Revenue forecast for InspireMD Inc?
Projected CAGR
58%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 58%.
What is the Gross Profit forecast for InspireMD Inc?
Projected CAGR
97%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is 97%.
